A clinical study found that patients showed 100% and 99.7% treatment rates for spontaneous ventricular tachyarrhythmias and acute ventricular tachyarrhythmias, respectively, 12 months after receiving Boston Scientific's subcutaneous implantable cardioverter defibrillator, or S-ICD system. The findings were based on real-world data from more than 450 patients with abnormal heart rhythms.

Related Summaries